{"id":"W2746676535","doi":"10.1007/s10120-017-0754-1","title":"Health-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinoma","year":2017,"lang":"en","type":"article","venue":"Gastric Cancer","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute; Medical Research Council; National Health and Medical Research Council; Bayer","keywords":"Medicine; Regorafenib; Quality of life (healthcare); Randomized controlled trial; Internal medicine; Discontinuation; Physical therapy; Oncology; Cancer; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004371248,0.0003140829,0.001200021,0.0003580218,0.0001662634,0.00002728263,0.0002304292,0.0001062,0.0002229422],"category_scores_gemma":[0.0003860325,0.000250573,0.0001659699,0.0005772082,0.0001532311,0.0001854586,0.00006925346,0.0002539002,0.000006019519],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001596943,"about_ca_system_score_gemma":0.0009295354,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01485043,"about_ca_topic_score_gemma":0.006603512,"domain_scores_codex":[0.9973609,0.000114909,0.0009009709,0.0004956942,0.0005164631,0.0006110113],"domain_scores_gemma":[0.9972227,0.0001036903,0.001385842,0.0008696027,0.0001396479,0.0002785626],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001331823,0.0004164738,0.9450245,0.0001145551,0.0003050299,0.00004441658,0.0002419983,0.0001181796,0.00006371131,0.00002817885,0.0008949944,0.05141608],"study_design_scores_gemma":[0.01290596,0.001357543,0.9841399,0.0003160919,0.0001249166,0.000006887293,0.0001792738,0.0000516356,0.00001962097,0.00001386018,0.000705762,0.0001785288],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9888763,0.004426687,0.00003692227,0.003762438,0.0002656241,0.001047753,0.00005430308,0.0000663655,0.001463612],"genre_scores_gemma":[0.9944885,0.001165244,0.0002273088,0.0002120553,0.00007941965,0.0001362661,0.00005033192,0.00003788707,0.003602985],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05123755,"threshold_uncertainty_score":0.9999946,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05296989581928377,"score_gpt":0.335803470103708,"score_spread":0.2828335742844242,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}